Search results
Showing 121 to 135 of 159 results for fibrosis
Summary of the evidence on the antimicrobial prescribing of ceftolozane with tazobactam for hospital-acquired pneumonia, including ventilator-associated
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes (TA943)
Evidence-based recommendations on hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.
from guidance Mannitol dry powder for inhalation for treating cystic fibrosis Number TA266 Date issued November 2012 Other
director, content and channels) Close family member works for the Cystic Fibrosis Trust. Nichole Taske (associate centre director,...
director, content and channels) Close family member works for the Cystic Fibrosis Trust. Nichole Taske (associate centre director,...
director, content and channels) Close family member works for the Cystic Fibrosis Trust. Nichole Taske (associate centre director,...
Awaiting development [GID-TA11372] Expected publication date: TBC
Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumab (ESUOM44)
Summary of the evidence on eculizumab to prevent the recurrence of C3 glomerulopathy post-transplant to inform local NHS planning and decision-making
Highly specialised technologies evaluation committee members
Highly specialised technologies evaluation committee members
NICE has developed a medtech innovation briefing (MIB) on OxyMask for delivering oxygen therapy .
C3 glomerulopathy in the native kidney: eculizumab (ESUOM49)
Summary of the evidence on eculizumab for treating C3 glomerulopathy in the native kidney inform local NHS planning and decision-making
This guideline covers managing and monitoring diabetic retinopathy in people under the care of hospital eye services. This includes non-proliferative and proliferative diabetic retinopathy, and diabetic macular oedema.
This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without antibiotics. Serious complications are rare.
This evidence summary has been updated and replaced by NICE guideline NG78.